Villalobos-Molina R, Ibarra M
Departamento de Farmacología y Toxicología, Centro de Investigación y de Estudios Avanzados del Instituto Politécnico Nacional, México, D.F., Mexico.
Arch Med Res. 1999 Sep-Oct;30(5):347-52. doi: 10.1016/s0188-0128(99)00047-0.
Heterogeneity of vascular alpha 1-adrenoceptor subtypes has been revealed by pharmacological and molecular biology studies (i.e., alpha 1A-, alpha 1B-, and alpha 1D-adrenoceptors). The alpha 1D-adrenoceptor subtype is predominantly involved in the contraction of a variety of vessels and its role in the control of blood pressure has been suggested, a phenomenon probably related to aging. Recent advances in the use of young pre-hypertensive rats and adult spontaneously hypertensive rats with one kidney and Grollman-type renal hypertension suggest vascular alpha 1D-adrenoceptor involvement in the increased blood pressure. The possible role of alpha 1D-adrenoceptors in the genesis/maintenance of hypertension is discussed in this review.
药理学和分子生物学研究(即α1A-、α1B-和α1D-肾上腺素能受体)揭示了血管α1-肾上腺素能受体亚型的异质性。α1D-肾上腺素能受体亚型主要参与多种血管的收缩,并且有人提出了其在血压控制中的作用,这一现象可能与衰老有关。使用年轻的高血压前期大鼠以及成年单肾自发性高血压大鼠和格罗曼型肾性高血压大鼠的最新研究进展表明,血管α1D-肾上腺素能受体与血压升高有关。本文综述讨论了α1D-肾上腺素能受体在高血压发生/维持中的可能作用。